WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996005845) TREATMENT OF DISEASE AND CONDITIONS ASSOCIATED WITH MACROPHAGE INFILTRATION IN PARTICULAR STROKE AND MYOCARDIAL INFARCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/005845    International Application No.:    PCT/CA1995/000467
Publication Date: 29.02.1996 International Filing Date: 02.08.1995
Chapter 2 Demand Filed:    20.03.1996    
IPC:
A61K 31/728 (2006.01), A61K 45/06 (2006.01)
Applicants: HYAL PHARMACEUTICAL CORPORATION [CA/CA]; 2425 Skymark Avenue, Mississauga, Ontario L4W 4Y6 (CA) (For All Designated States Except US).
TURLEY, Eva, Anne [CA/CA]; (CA) (For US Only).
ASCULAI, Samuel, Simon [US/CA]; (CA) (For US Only)
Inventors: TURLEY, Eva, Anne; (CA).
ASCULAI, Samuel, Simon; (CA)
Agent: HUGHES, Ivor, M.; Suite 200, 175 Commerce Valley Drive West, Thornhill, Ontario L3T 7P6 (CA)
Priority Data:
2,130,762 24.08.1994 CA
Title (EN) TREATMENT OF DISEASE AND CONDITIONS ASSOCIATED WITH MACROPHAGE INFILTRATION IN PARTICULAR STROKE AND MYOCARDIAL INFARCTION
(FR) TRAITEMENT DE MALADIES ET DE TROUBLES ASSOCIES A DES INFILTRATIONS DE MACROPHAGES, NOTAMMENT LES APOPLEXIES ET LES INFARCTUS DU MYOCARDE
Abstract: front page image
(EN)Use of hyaluronic acid and/or salts thereof for the treatment of a human having a disease or condition characterized by macrophage, neutrophile or other white blood cell infiltration into an area damaged by the disease or condition, wherein said use comprises the use of an effective amount of hyaluronic acid and/or salts thereof for a period of time until such use is no longer required.
(FR)On décrit l'utilisation de l'acide hyaluronique et/ou de ses sels pour traiter un patient souffrant d'une maladie ou d'un trouble caractérisé par l'infiltration de macrophages, de neutrophiles ou d'autres globules blancs dans une zone touchée par cette maladie ou ce trouble. Cette utilisation concerne l'administration d'une quantité efficace d'acide hyaluronique et/ou de ses sels pendant la durée qui s'impose.
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)